DCF — BAYLOR S&W MEDICAL CENTER - PLANO
Enterprise Value: $52.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$52.5M
Enterprise Value
$9.2M
PV of Cash Flows
$43.3M
PV of Terminal Value
$69.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $249.8M | $11.2M | 4.0% | $-0.6M | $-0.6M |
| Year 2 | $257.3M | $14.1M | 5.0% | $1.3M | $1.1M |
| Year 3 | $265.0M | $17.2M | 6.0% | $3.3M | $2.5M |
| Year 4 | $272.9M | $19.1M | 7.0% | $4.4M | $3.0M |
| Year 5 | $281.1M | $20.3M | 7.0% | $5.1M | $3.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $52.5M. Terminal value accounts for 82% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$242.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.03981096933377238
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5